Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 18 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 5 |
NetGPI | no | yes: 0, no: 5 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 5 |
GO:0110165 | cellular anatomical entity | 1 | 5 |
GO:0005789 | endoplasmic reticulum membrane | 4 | 3 |
GO:0031090 | organelle membrane | 3 | 3 |
Related structures:
AlphaFold database: E8NHG0
Term | Name | Level | Count |
---|---|---|---|
GO:0006629 | lipid metabolic process | 3 | 1 |
GO:0006638 | neutral lipid metabolic process | 4 | 1 |
GO:0006639 | acylglycerol metabolic process | 5 | 1 |
GO:0006641 | triglyceride metabolic process | 6 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0008610 | lipid biosynthetic process | 4 | 1 |
GO:0009058 | biosynthetic process | 2 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0019432 | triglyceride biosynthetic process | 6 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0044249 | cellular biosynthetic process | 3 | 1 |
GO:0044255 | cellular lipid metabolic process | 3 | 1 |
GO:0045017 | glycerolipid biosynthetic process | 4 | 1 |
GO:0046460 | neutral lipid biosynthetic process | 4 | 1 |
GO:0046463 | acylglycerol biosynthetic process | 5 | 1 |
GO:0046486 | glycerolipid metabolic process | 4 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:1901576 | organic substance biosynthetic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 6 |
GO:0008374 | O-acyltransferase activity | 5 | 6 |
GO:0016740 | transferase activity | 2 | 6 |
GO:0016746 | acyltransferase activity | 3 | 6 |
GO:0016747 | acyltransferase activity, transferring groups other than amino-acyl groups | 4 | 6 |
GO:0004144 | diacylglycerol O-acyltransferase activity | 7 | 1 |
GO:0016411 | acylglycerol O-acyltransferase activity | 6 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 218 | 220 | PF00675 | 0.381 |
CLV_NRD_NRD_1 | 9 | 11 | PF00675 | 0.368 |
CLV_PCSK_KEX2_1 | 218 | 220 | PF00082 | 0.381 |
CLV_PCSK_KEX2_1 | 226 | 228 | PF00082 | 0.290 |
CLV_PCSK_KEX2_1 | 9 | 11 | PF00082 | 0.368 |
CLV_PCSK_PC1ET2_1 | 226 | 228 | PF00082 | 0.290 |
CLV_PCSK_SKI1_1 | 250 | 254 | PF00082 | 0.381 |
CLV_PCSK_SKI1_1 | 67 | 71 | PF00082 | 0.315 |
CLV_Separin_Metazoa | 240 | 244 | PF03568 | 0.581 |
DEG_APCC_DBOX_1 | 267 | 275 | PF00400 | 0.581 |
DEG_Nend_Nbox_1 | 1 | 2 | PF02207 | 0.581 |
DOC_MAPK_DCC_7 | 268 | 277 | PF00069 | 0.521 |
DOC_MAPK_gen_1 | 226 | 234 | PF00069 | 0.490 |
DOC_MAPK_gen_1 | 290 | 298 | PF00069 | 0.664 |
DOC_MAPK_gen_1 | 46 | 56 | PF00069 | 0.222 |
DOC_MAPK_HePTP_8 | 265 | 277 | PF00069 | 0.581 |
DOC_MAPK_MEF2A_6 | 268 | 277 | PF00069 | 0.521 |
DOC_MAPK_MEF2A_6 | 290 | 298 | PF00069 | 0.664 |
DOC_MAPK_MEF2A_6 | 49 | 56 | PF00069 | 0.246 |
DOC_MAPK_NFAT4_5 | 49 | 57 | PF00069 | 0.249 |
DOC_PP1_RVXF_1 | 113 | 120 | PF00149 | 0.381 |
DOC_PP4_FxxP_1 | 199 | 202 | PF00568 | 0.484 |
DOC_USP7_MATH_1 | 25 | 29 | PF00917 | 0.533 |
DOC_USP7_MATH_1 | 264 | 268 | PF00917 | 0.581 |
LIG_14-3-3_CanoR_1 | 118 | 126 | PF00244 | 0.324 |
LIG_14-3-3_CanoR_1 | 188 | 198 | PF00244 | 0.581 |
LIG_14-3-3_CanoR_1 | 218 | 222 | PF00244 | 0.581 |
LIG_14-3-3_CanoR_1 | 227 | 232 | PF00244 | 0.479 |
LIG_14-3-3_CanoR_1 | 243 | 253 | PF00244 | 0.554 |
LIG_14-3-3_CanoR_1 | 26 | 31 | PF00244 | 0.569 |
LIG_14-3-3_CanoR_1 | 293 | 297 | PF00244 | 0.661 |
LIG_14-3-3_CanoR_1 | 3 | 7 | PF00244 | 0.722 |
LIG_Actin_WH2_2 | 167 | 183 | PF00022 | 0.472 |
LIG_Actin_WH2_2 | 194 | 212 | PF00022 | 0.484 |
LIG_Actin_WH2_2 | 33 | 51 | PF00022 | 0.217 |
LIG_APCC_ABBAyCdc20_2 | 124 | 130 | PF00400 | 0.381 |
LIG_BRCT_BRCA1_1 | 115 | 119 | PF00533 | 0.381 |
LIG_BRCT_BRCA1_1 | 195 | 199 | PF00533 | 0.490 |
LIG_BRCT_BRCA1_1 | 27 | 31 | PF00533 | 0.459 |
LIG_FHA_1 | 256 | 262 | PF00498 | 0.531 |
LIG_FHA_1 | 45 | 51 | PF00498 | 0.349 |
LIG_GBD_Chelix_1 | 80 | 88 | PF00786 | 0.217 |
LIG_LIR_Apic_2 | 196 | 202 | PF02991 | 0.490 |
LIG_LIR_Gen_1 | 116 | 127 | PF02991 | 0.381 |
LIG_LIR_Gen_1 | 168 | 179 | PF02991 | 0.472 |
LIG_LIR_Gen_1 | 258 | 266 | PF02991 | 0.581 |
LIG_LIR_Nem_3 | 116 | 122 | PF02991 | 0.379 |
LIG_LIR_Nem_3 | 168 | 174 | PF02991 | 0.485 |
LIG_LIR_Nem_3 | 258 | 263 | PF02991 | 0.563 |
LIG_PDZ_Class_2 | 293 | 298 | PF00595 | 0.488 |
LIG_SH2_CRK | 57 | 61 | PF00017 | 0.249 |
LIG_SH2_GRB2like | 134 | 137 | PF00017 | 0.315 |
LIG_SH2_NCK_1 | 57 | 61 | PF00017 | 0.249 |
LIG_SH2_STAT5 | 100 | 103 | PF00017 | 0.550 |
LIG_SH2_STAT5 | 126 | 129 | PF00017 | 0.310 |
LIG_SH2_STAT5 | 134 | 137 | PF00017 | 0.278 |
LIG_SH2_STAT5 | 155 | 158 | PF00017 | 0.279 |
LIG_SH2_STAT5 | 189 | 192 | PF00017 | 0.581 |
LIG_SH2_STAT5 | 62 | 65 | PF00017 | 0.428 |
LIG_SH3_3 | 138 | 144 | PF00018 | 0.381 |
LIG_SH3_3 | 19 | 25 | PF00018 | 0.556 |
LIG_SH3_3 | 267 | 273 | PF00018 | 0.515 |
LIG_SUMO_SIM_anti_2 | 230 | 235 | PF11976 | 0.515 |
LIG_SUMO_SIM_par_1 | 230 | 235 | PF11976 | 0.581 |
LIG_SUMO_SIM_par_1 | 250 | 255 | PF11976 | 0.554 |
LIG_TYR_ITIM | 98 | 103 | PF00017 | 0.472 |
LIG_WRC_WIRS_1 | 156 | 161 | PF05994 | 0.472 |
MOD_CK1_1 | 113 | 119 | PF00069 | 0.380 |
MOD_CK1_1 | 217 | 223 | PF00069 | 0.472 |
MOD_GlcNHglycan | 104 | 107 | PF01048 | 0.478 |
MOD_GlcNHglycan | 247 | 250 | PF01048 | 0.217 |
MOD_GlcNHglycan | 31 | 34 | PF01048 | 0.332 |
MOD_GSK3_1 | 113 | 120 | PF00069 | 0.472 |
MOD_GSK3_1 | 189 | 196 | PF00069 | 0.472 |
MOD_GSK3_1 | 217 | 224 | PF00069 | 0.384 |
MOD_GSK3_1 | 241 | 248 | PF00069 | 0.345 |
MOD_GSK3_1 | 25 | 32 | PF00069 | 0.472 |
MOD_NEK2_1 | 170 | 175 | PF00069 | 0.485 |
MOD_NEK2_1 | 214 | 219 | PF00069 | 0.485 |
MOD_NEK2_1 | 232 | 237 | PF00069 | 0.207 |
MOD_NEK2_1 | 241 | 246 | PF00069 | 0.279 |
MOD_NEK2_2 | 155 | 160 | PF00069 | 0.472 |
MOD_PIKK_1 | 110 | 116 | PF00454 | 0.472 |
MOD_PIKK_1 | 150 | 156 | PF00454 | 0.472 |
MOD_PIKK_1 | 241 | 247 | PF00454 | 0.402 |
MOD_PIKK_1 | 252 | 258 | PF00454 | 0.367 |
MOD_PK_1 | 227 | 233 | PF00069 | 0.472 |
MOD_PKA_2 | 117 | 123 | PF00069 | 0.472 |
MOD_PKA_2 | 2 | 8 | PF00069 | 0.670 |
MOD_PKA_2 | 217 | 223 | PF00069 | 0.472 |
MOD_PKA_2 | 25 | 31 | PF00069 | 0.458 |
MOD_PKA_2 | 292 | 298 | PF00069 | 0.586 |
MOD_Plk_1 | 150 | 156 | PF00069 | 0.494 |
MOD_Plk_1 | 221 | 227 | PF00069 | 0.380 |
MOD_Plk_4 | 193 | 199 | PF00069 | 0.397 |
MOD_Plk_4 | 227 | 233 | PF00069 | 0.321 |
MOD_Plk_4 | 26 | 32 | PF00069 | 0.217 |
MOD_Plk_4 | 74 | 80 | PF00069 | 0.293 |
TRG_DiLeu_BaLyEn_6 | 199 | 204 | PF01217 | 0.472 |
TRG_DiLeu_BaLyEn_6 | 270 | 275 | PF01217 | 0.472 |
TRG_ENDOCYTIC_2 | 100 | 103 | PF00928 | 0.452 |
TRG_ENDOCYTIC_2 | 134 | 137 | PF00928 | 0.321 |
TRG_ENDOCYTIC_2 | 57 | 60 | PF00928 | 0.356 |
TRG_ER_diArg_1 | 8 | 10 | PF00400 | 0.456 |
TRG_Pf-PMV_PEXEL_1 | 138 | 142 | PF00026 | 0.472 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0S4JRA5 | Bodo saltans | 42% | 100% |
A0A3S7X0T2 | Leishmania donovani | 96% | 90% |
A4I2V0 | Leishmania infantum | 96% | 90% |
E9ADD8 | Leishmania major | 95% | 100% |
O74850 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 30% | 86% |
Q2KHS5 | Xenopus laevis | 28% | 89% |
Q54GC1 | Dictyostelium discoideum | 28% | 90% |
Q6ZPD8 | Homo sapiens | 26% | 88% |
Q70VZ7 | Bos taurus | 28% | 89% |
Q91ZV4 | Mus musculus | 28% | 89% |
Q96PD6 | Homo sapiens | 26% | 89% |